Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Nurix Therapeutics (NRIX) over the last 4 years, with Nov 2024 value amounting to $67.1 million.

  • Nurix Therapeutics' Shares Outstanding (Diluted Average) rose 15.64% to $84.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $84.2 million, marking a year-over-year increase of 15.64%. This contributed to the annual value of $67.1 million for FY2024, which is 23.52% up from last year.
  • According to the latest figures from FY2024, Nurix Therapeutics' Shares Outstanding (Diluted Average) is $67.1 million, which was up 23.52% from $54.3 million recorded in FY2023.
  • Nurix Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $67.1 million for FY2024, and its period low was $42.9 million during FY2021.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $54.3 million (2023), whereas its average is $56.7 million.
  • Data for Nurix Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY rose of 23.52% (in 2024) over the last 5 years.
  • Over the past 4 years, Nurix Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $42.9 million in 2021, then climbed by 13.32% to $48.6 million in 2022, then rose by 11.79% to $54.3 million in 2023, then grew by 23.52% to $67.1 million in 2024.